VESTECK, Inc is an innovative startup in the Health Care and Manufacturing industries, founded in 2019. The company's flagship product, the "SUTURE-TIGHT" tm catheter, has intrigued endovascular clinicians globally. This groundbreaking device is designed to secure endovascular aortic repair grafts to the aorta during initial implant or repair procedures, catering to the needs of EVAR/TEVAR/TAVR procedures. Despite its immense potential, the device is not commercially available yet. The startup recently received a Convertible Note investment in January 2024, with Robin Hood Ventures participating as the investor. This latest investment reflects the growing enthusiasm and confidence in VESTECK's disruptive technology, poised to make waves in the health care sector.
No recent news or press coverage available for VESTECK, Inc.